Previous Article | Next Article 
Infection and Immunity, November 2001, p. 6942-6950, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6942-6950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Dual Role of Lipopolysaccharide (LPS)-Binding Protein
in Neutralization of LPS and Enhancement of LPS-Induced
Activation of Mononuclear Cells
Thomas
Gutsmann,1
Mareike
Müller,1
Stephen
F.
Carroll,2
Roger C.
MacKenzie,3
Andre
Wiese,1 and
Ulrich
Seydel1,*
Department of Immunochemistry and Biochemical
Microbiology, Center for Medicine and Biosciences, Research Center
Borstel, D-23845 Borstel, Germany1; XOMA
(US) LLC, Berkeley, California 947102; and
Institute for Biological Sciences, National Research Council of
Canada, Ottawa, Ontario, Canada K1A OR63
Received 26 April 2001/Returned for modification 2 August
2001/Accepted 20 August 2001
The lipopolysaccharide (LPS)-binding protein (LBP) has a
concentration-dependent dual role in the pathogenesis of gram-negative sepsis: low concentrations of LBP enhance the LPS-induced activation of
mononuclear cells (MNC), whereas the acute-phase rise in LBP concentrations inhibits LPS-induced cellular stimulation. In
stimulation experiments, we have found that LBP mediates the
LPS-induced cytokine release from MNC even under serum-free conditions.
In biophysical experiments we demonstrated that LBP binds and
intercalates into lipid membranes, amplified by negative charges of the
latter, and that intercalated LBP can mediate the CD14-independent
intercalation of LPS into membranes in a lipid-specific and
temperature-dependent manner. In contrast, prior complexation of LBP
and LPS inhibited binding of these complexes to membranes due to
different binding of LBP to LPS or phospholipids. This results in a
neutralization of LPS and, therefore, to a reduced production of tumor
necrosis factor by MNC. We propose that LBP is not only present as a
soluble protein in the serum but may also be incorporated as a
transmembrane protein in the cytoplasmic membrane of MNC and that the
interaction of LPS with membrane-associated LBP may be an important
step in LBP-mediated activation of MNC, whereas LBP-LPS complexation in the serum leads to a neutralization of LPS.
*
Corresponding author. Mailing address: Research Center
Borstel, Center for Medicine and Biosciences, Department of
Immunochemistry and Biochemical Microbiology, Parkallee 10, D-23845
Borstel, Germany. Phone: 49 (0) 4537 188-232. Fax: 49 (0) 4537 188-632. E-mail: useydel{at}fz-borstel.de.
Infection and Immunity, November 2001, p. 6942-6950, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6942-6950.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Minter, R. M., Bi, X., Ben-Josef, G., Wang, T., Hu, B., Arbabi, S., Hemmila, M. R., Wang, S. C., Remick, D. G., Su, G. L.
(2009). LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am. J. Physiol. Gastrointest. Liver Physiol.
296: G45-G54
[Abstract]
[Full Text]
-
Lepper, P. M., Schumann, C., Triantafilou, K., Rasche, F. M., Schuster, T., Frank, H., Schneider, E. M., Triantafilou, M., von Eynatten, M.
(2007). Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men. J Am Coll Cardiol
50: 25-31
[Abstract]
[Full Text]
-
Schromm, A. B., Howe, J., Ulmer, A. J., Wiesmuller, K.-H., Seyberth, T., Jung, G., Rossle, M., Koch, M. H. J., Gutsmann, T., Brandenburg, K.
(2007). Physicochemical and Biological Analysis of Synthetic Bacterial Lipopeptides: VALIDITY OF THE CONCEPT OF ENDOTOXIC CONFORMATION. J. Biol. Chem.
282: 11030-11037
[Abstract]
[Full Text]
-
Mueller, M., Stamme, C., Draing, C., Hartung, T., Seydel, U., Schromm, A. B.
(2006). Cell Activation of Human Macrophages by Lipoteichoic Acid Is Strongly Attenuated by Lipopolysaccharide-binding Protein. J. Biol. Chem.
281: 31448-31456
[Abstract]
[Full Text]
-
Andra, J., Gutsmann, T., Garidel, P., Brandenburg, K.
(2006). Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds. Innate Immunity
12: 261-277
[Abstract]
-
Papavlassopoulos, M., Stamme, C., Thon, L., Adam, D., Hillemann, D., Seydel, U., Schromm, A. B.
(2006). MaxiK Blockade Selectively Inhibits the Lipopolysaccharide-Induced I{kappa}B-{alpha}/NF-{kappa}B Signaling Pathway in Macrophages. J. Immunol.
177: 4086-4093
[Abstract]
[Full Text]
-
Lehnert, M., Uehara, T., Bradford, B. U., Lind, H., Zhong, Z., Brenner, D. A., Marzi, I., Lemasters, J. J.
(2006). Lipopolysaccharide-binding protein modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Am. J. Physiol. Gastrointest. Liver Physiol.
291: G456-G463
[Abstract]
[Full Text]
-
Roes, S., Mumm, F., Seydel, U., Gutsmann, T.
(2006). Localization of the Lipopolysaccharide-binding Protein in Phospholipid Membranes by Atomic Force Microscopy. J. Biol. Chem.
281: 2757-2763
[Abstract]
[Full Text]
-
Satoh, M., Iwahori, T., Sugawara, N., Yamazaki, M.
(2006). Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities. Innate Immunity
12: 21-38
[Abstract]
-
Mueller, M., Lindner, B., Dedrick, R., Schromm, A.B., Seydel, U.
(2005). Endotoxin: physical requirements for cell activation. Innate Immunity
11: 299-303
[Abstract]
-
Schroder, N. W.J., Schumann, R. R.
(2005). Non-LPS targets and actions of LPS binding protein (LBP). Innate Immunity
11: 237-242
[Abstract]
-
Munford, R. S.
(2005). Invited review: Detoxifying endotoxin: time, place and person. Innate Immunity
11: 69-84
[Abstract]
-
Heinzelmann, M., Bosshart, H.
(2005). Heparin Binds to Lipopolysaccharide (LPS)-Binding Protein, Facilitates the Transfer of LPS to CD14, and Enhances LPS-Induced Activation of Peripheral Blood Monocytes. J. Immunol.
174: 2280-2287
[Abstract]
[Full Text]
-
Mueller, M., Brandenburg, K., Dedrick, R., Schromm, A. B., Seydel, U.
(2005). Phospholipids Inhibit Lipopolysaccharide (LPS)-Induced Cell Activation: A Role for LPS-Binding Protein. J. Immunol.
174: 1091-1096
[Abstract]
[Full Text]
-
Stoll, L. L., Denning, G. M., Li, W.-G., Rice, J. B., Harrelson, A. L., Romig, S. A., Gunnlaugsson, S. T., Miller, F. J. Jr, Weintraub, N. L.
(2004). Regulation of Endotoxin-Induced Proinflammatory Activation in Human Coronary Artery Cells: Expression of Functional Membrane-Bound CD14 by Human Coronary Artery Smooth Muscle Cells. J. Immunol.
173: 1336-1343
[Abstract]
[Full Text]
-
Mueller, M., Lindner, B., Kusumoto, S., Fukase, K., Schromm, A. B., Seydel, U.
(2004). Aggregates Are the Biologically Active Units of Endotoxin. J. Biol. Chem.
279: 26307-26313
[Abstract]
[Full Text]
-
Antonicelli, F., Brown, D., Parmentier, M., Drost, E. M., Hirani, N., Rahman, I., Donaldson, K., MacNee, W.
(2004). Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am. J. Physiol. Lung Cell. Mol. Physiol.
286: L1319-L1327
[Abstract]
[Full Text]
-
Kato, A., Ogasawara, T., Homma, T., Saito, H., Matsumoto, K.
(2004). Lipopolysaccharide-Binding Protein Critically Regulates Lipopolysaccharide-Induced IFN-{beta} Signaling Pathway in Human Monocytes. J. Immunol.
172: 6185-6194
[Abstract]
[Full Text]
-
Brandenburg, K., Garidel, P., Andra, J., Jurgens, G., Muller, M., Blume, A., Koch, M. H. J., Levin, J.
(2003). Cross-linked Hemoglobin Converts Endotoxically Inactive Pentaacyl Endotoxins into a Physiologically Active Conformation. J. Biol. Chem.
278: 47660-47669
[Abstract]
[Full Text]
-
Thompson, P. A., Tobias, P. S., Viriyakosol, S., Kirkland, T. N., Kitchens, R. L.
(2003). Lipopolysaccharide (LPS)-binding Protein Inhibits Responses to Cell-bound LPS. J. Biol. Chem.
278: 28367-28371
[Abstract]
[Full Text]
-
Muller, M., Scheel, O., Lindner, B., Gutsmann, T., Seydel, U.
(2003). The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. Innate Immunity
9: 181-186
[Abstract]
-
Wiese, A., Gutsmann, T., Seydel, U.
(2003). Review: Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. Innate Immunity
9: 67-84
[Abstract]
-
Stamme, C., Muller, M., Hamann, L., Gutsmann, T., Seydel, U.
(2002). Surfactant Protein A Inhibits Lipopolysaccharide-Induced Immune Cell Activation by Preventing the Interaction of Lipopolysaccharide with Lipopolysaccharide-Binding Protein. Am. J. Respir. Cell Mol. Bio.
27: 353-360
[Abstract]
[Full Text]
-
Fierer, J., Swancutt, M. A., Heumann, D., Golenbock, D.
(2002). The Role of Lipopolysaccharide Binding Protein in Resistance to Salmonella Infections in Mice. J. Immunol.
168: 6396-6403
[Abstract]
[Full Text]